LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Incoming Lazard CEO sets goal to double revenue by 2030

Clyde Edgerton by Clyde Edgerton
September 14, 2023
in Markets
Incoming Lazard CEO sets goal to double revenue by 2030
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

[ad_1]

You might also like

Trump Keeps Gambling With the Economy — And Getting Away With It

‘I’ve won affordability’: Trump previews SOTU in Georgia rally

Trump in Iowa tries to shift the conversation back to the economy

Incoming Lazard Ltd.
LAZ,
+0.85%
Chief Executive Peter Orszag on Thursday said he plans to steer the investment bank to double its revenue by 2030, according to a letter posted on its website. The investment bank is currently projected to generate about $2.48 billion in revenue in 2023, according to FactSet consensus estimates. Doubling that figure would translate to about $5 billion in revenue over the next seven years. Orszag formally begins work as chief executive on Oct. 1. The firm’s 2030 revenue target would be realized through double-digit revenue growth annually on average, which would be “more in line with how similarly sized peers have grown through the cycle,” Orszag said. The revenue increase will be split about evenly between Lazard’s asset management unit and its advisory business Lazard also plans to average total shareholder return of 10% to 15% per year through 2030. Among the executive changes at the firm, Alexandra Soto, a senior partner, was named as Lazard’s chief operating officer. Chris Weideman will join Lazard as general counsel after working previously at Apollo Global Management Inc.
APO,
-0.16%.
Lazard stock was up 1.1% in premarket trades.

[ad_2]

Source link

Share30Tweet19
Previous Post

Bristol Myers Squibb set to double number of drugs in registrational trials

Next Post

DeFi as a solution in times of crisis

Clyde Edgerton

Clyde Edgerton

Recommended For You

Trump Keeps Gambling With the Economy — And Getting Away With It
Markets

Trump Keeps Gambling With the Economy — And Getting Away With It

March 5, 2026
‘I’ve won affordability’: Trump previews SOTU in Georgia rally
Markets

‘I’ve won affordability’: Trump previews SOTU in Georgia rally

February 19, 2026
Trump in Iowa tries to shift the conversation back to the economy
Markets

Trump in Iowa tries to shift the conversation back to the economy

January 28, 2026
Americans give Trump low marks on handling of economy as midterms likely to center on affordability
Markets

Americans give Trump low marks on handling of economy as midterms likely to center on affordability

January 16, 2026
Next Post
DeFi as a solution in times of crisis

DeFi as a solution in times of crisis

Related News

Bybit integrates Avalon through CeFi to DeFi bridge for Bitcoin yield

Bybit integrates Avalon through CeFi to DeFi bridge for Bitcoin yield

April 14, 2025
Sunak and AI leaders discuss ‘existential threats’ and disinformation fears

Sunak and AI leaders discuss ‘existential threats’ and disinformation fears

May 24, 2023
Bitcoin miner IREN overstated its compute ability and prospects, says lawsuit

Bitcoin miner IREN overstated its compute ability and prospects, says lawsuit

October 10, 2024

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?